| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |